Coumadin Recalled

Bristol-Myers Squibb has alerted the FDA and initiated the recall of one lot of Coumadin, after an oversized tablet was discovered. Coumadin, also known as warfarin, is an anticoagulant or blood thinner prescribed for individuals with an increased risk of blood clots. An overdose would create an increased risk of bleeding.

The recall applies to 5-milligram Coumadin tablets with an expiration date of Sept. 30, 2012 and production lot number 9H49374A.

Bottles of 1000 tablets were included in this particular lot, so individuals taking Coumadin need to check with the pharmacy that dispensed it to know if their prescriptions were affected.

Anyone who is adversely affected by this lot of Coumadin is asked to contact the FDA’s MedWatch Safety Information and Adverse Event Reporting Program either online or by calling the FDA at 1-800-332-1088

Bookmark and Share

Comments are closed.